Values First Advisors Inc. Sells 2,282 Shares of Medifast, Inc. (NYSE:MED)

Values First Advisors Inc. lowered its position in shares of Medifast, Inc. (NYSE:MED) by 3.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 61,888 shares of the specialty retailer’s stock after selling 2,282 shares during the quarter. Values First Advisors Inc. owned about 0.57% of Medifast worth $1,090,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of the business. Exchange Traded Concepts LLC lifted its stake in shares of Medifast by 4.1% in the 4th quarter. Exchange Traded Concepts LLC now owns 17,106 shares of the specialty retailer’s stock valued at $301,000 after purchasing an additional 674 shares during the period. Inspire Investing LLC lifted its stake in Medifast by 11.1% in the fourth quarter. Inspire Investing LLC now owns 54,270 shares of the specialty retailer’s stock valued at $956,000 after buying an additional 5,403 shares during the period. Nisa Investment Advisors LLC boosted its holdings in shares of Medifast by 2,308.8% during the 4th quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after buying an additional 10,967 shares in the last quarter. Commons Capital LLC boosted its holdings in shares of Medifast by 38.5% during the 4th quarter. Commons Capital LLC now owns 38,000 shares of the specialty retailer’s stock worth $670,000 after buying an additional 10,563 shares in the last quarter. Finally, JPMorgan Chase & Co. grew its position in shares of Medifast by 156.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer’s stock worth $1,100,000 after buying an additional 35,017 shares during the period. 95.51% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Separately, DA Davidson raised shares of Medifast from an “underperform” rating to a “neutral” rating and increased their target price for the stock from $16.50 to $17.00 in a research note on Tuesday, November 5th.

Medifast Stock Performance

Shares of MED opened at $15.12 on Wednesday. Medifast, Inc. has a one year low of $14.88 and a one year high of $56.52. The company has a market cap of $165.42 million, a PE ratio of 22.91 and a beta of 1.14. The stock has a 50-day moving average of $16.96 and a 200-day moving average of $18.21. The company has a debt-to-equity ratio of 0.06, a current ratio of 3.11 and a quick ratio of 2.55.

About Medifast

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.